VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission.
A complete response with combination chemotherapy was obtained in a patient with metastatic Merkel cell carcinoma. This complete response lasted 15 months. This case report demonstrates the chemosensitivity of this metastatic disease when treated with combination chemotherapy.